Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
electroCore, Inc. (ECOR)
USD6.08
-0.08 (-1.22%)
US NASDAQ Healthcare Medical - Devices
Address
200 Forge Way 7866
Rockaway, NJ, US
Rockaway, NJ, US
CEO
Thomas J. Errico
Website
electrocore.com
IPO
2018-06-22
CIK 1560258 ISIN US28531P2020
Description
electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD6.08
-0.08 (-1.22%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
106.3K
Beta
0.87
Float Shares
5.08M
Free Float %
62.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +3.12% | +0.30% | +8.72% | +18.25% | +9.08% | +47.22% | +37.14% | +1.54% | -72.80% | -97.78% | -97.78% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (6 ratings, all time)
Buy
Price Targets & DCF
Current price
6.08
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 4 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-17.10
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%+27.2% ★ Q1'26: +42.6% (vs Q1'25)
-
EPS growth Medical - Devices: +28.5%-3.8% Q1'26: -25.5% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%-33.8% Q1'26: -31.4% (vs Q1'25)
-
EBIT margin Medical - Devices: +6.2%-41.1% Q1'26: -55.5% (vs Q1'25)
-
ROIC Medical - Devices: +3.3%— Q1'26: +398.2% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%+13.4% Q1'26: +8.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×-0.82× Q1'26: -0.45× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 3 EPS Ana. |
Dec 2027 4 Rev. Ana. 2 EPS Ana. |
Dec 2028 4 Rev. Ana. 2 EPS Ana. |
Dec 2029 3 Rev. Ana. 1 EPS Ana. |
Dec 2030 3 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
993.0K
est: 900.7K (+10.2%)
|
2.39M
est: 2.66M (-10.0%)
|
3.50M
est: 3.47M (+0.6%)
|
5.45M
est: 5.48M (-0.6%)
|
8.59M
est: 8.38M (+2.5%)
|
16.03M
est: 21.28M (-24.7%)
|
25.18M
est: 25.19M (0.0%)
|
32.03M
est: 31.92M (+0.3%)
|
42.38M
42.35M – 42.41M
+32.8% YoY
|
54.50M
53.03M – 55.97M
+28.6% YoY
|
70.99M
70.50M – 71.47M
+30.2% YoY
|
74.76M
72.46M – 76.96M
+5.3% YoY
|
87.04M
84.37M – 89.60M
+16.4% YoY
|
| EBITDA |
-54.49M
est: -798.5K (-6,723.4%)
|
-43.84M
est: -2.36M (-1,761.6%)
|
-23.88M
est: -3.08M (-675.4%)
|
-19.66M
est: -4.86M (-304.5%)
|
-22.28M
est: -7.43M (-199.8%)
|
-17.76M
est: -16.14M (-10.1%)
|
-10.90M
est: -19.10M (+42.9%)
|
-11.48M
est: -24.21M (+52.6%)
|
-32.14M
-32.16M – -32.11M
-32.8% YoY
|
-41.33M
-42.44M – -40.21M
-28.6% YoY
|
-53.83M
-54.20M – -53.46M
-30.2% YoY
|
-56.69M
-58.35M – -54.95M
-5.3% YoY
|
-66.00M
-67.94M – -63.98M
-16.4% YoY
|
| EBIT |
-54.55M
est: -807.5K (-6,655.6%)
|
-44.09M
est: -2.38M (-1,751.3%)
|
-24.28M
est: -3.11M (-679.6%)
|
-20.04M
est: -4.91M (-307.8%)
|
-22.87M
est: -7.51M (-204.4%)
|
-19.02M
est: -16.57M (-14.8%)
|
-12.16M
est: -19.62M (+38.0%)
|
-13.15M
est: -24.86M (+47.1%)
|
-33.00M
-33.03M – -32.98M
-32.8% YoY
|
-42.44M
-43.58M – -41.30M
-28.6% YoY
|
-55.28M
-55.66M – -54.90M
-30.2% YoY
|
-58.22M
-59.93M – -56.43M
-5.3% YoY
|
-67.78M
-69.78M – -65.70M
-16.4% YoY
|
| Net Income |
-55.82M
est: -187.45M (+70.2%)
|
-45.15M
est: -170.43M (+73.5%)
|
-23.51M
est: -66.05M (+64.4%)
|
-17.22M
est: -32.74M (+47.4%)
|
-22.16M
est: -34.99M (+36.7%)
|
-18.83M
est: -18.39M (-2.4%)
|
-11.89M
est: -12.57M (+5.4%)
|
-13.97M
est: -14.58M (+4.2%)
|
-12.57M
-13.68M – -12.30M
+13.8% YoY
|
-3.48M
-5.26M – -1.70M
+72.3% YoY
|
5.12M
-390.7K – 10.63M
+247.2% YoY
|
3.05M
2.93M – 3.17M
-40.3% YoY
|
7.63M
7.33M – 7.93M
+150.0% YoY
|
| SGA |
42.50M
est: 2.87M (+1,380.0%)
|
35.42M
est: 8.47M (+318.2%)
|
21.84M
est: 11.08M (+97.2%)
|
21.57M
est: 17.48M (+23.4%)
|
24.33M
est: 26.72M (-9.0%)
|
26.71M
est: 46.34M (-42.4%)
|
31.20M
est: 54.86M (-43.1%)
|
38.21M
est: 69.51M (-45.0%)
|
92.29M
92.22M – 92.35M
+32.8% YoY
|
118.68M
115.47M – 121.86M
+28.6% YoY
|
154.57M
153.51M – 155.63M
+30.2% YoY
|
162.79M
157.79M – 167.57M
+5.3% YoY
|
189.53M
183.71M – 195.11M
+16.4% YoY
|
| EPS |
-28.61
est: -25.05 (-14.2%)
|
-23.05
est: -22.78 (-1.2%)
|
-9.04
est: -8.83 (-2.4%)
|
-4.36
est: -4.38 (+0.3%)
|
-4.69
est: -4.60 (-1.9%)
|
-3.42
est: -2.17 (-57.6%)
|
-1.59
est: -1.50 (-5.9%)
|
-1.65
est: -1.72 (+4.3%)
|
-1.52
-1.61 – -1.45
+12.1% YoY
|
-0.41
-0.62 – -0.20
+72.9% YoY
|
0.60
-0.05 – 1.25
+247.2% YoY
|
0.36
0.35 – 0.37
-40.3% YoY
|
0.90
0.86 – 0.93
+150.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-06 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-6.10M
OE per share TTM
-0.71
Owner's Yield
-10.23%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
9.1%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
5
Total invested
778.2K
Insider transactions (90d)
0
Beneficial owners (>5%)
15
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Joseph P. Errico | 3.97M | 13.31% | 1.55M | 2.42M | 1.55M | 2.42M | IN | USA | 2019-11-21 | ↗ |
| 2 | Kyle L. Newcomer | 3.52M | 4.90% | 3.52M | — | 3.52M | — | IN | United States | 2022-02-10 | ↗ |
| 3 | Thomas Errico | 3.50M | 11.73% | 1.01M | 2.42M | 1.01M | 2.42M | IN | USA | 2019-11-21 | ↗ |
| 4 | Merck & Co., Inc. | 3.35M | 11.80% | 3.35M | — | 3.35M | — | CO | New Jersey | 2018-06-27 | ↗ |
| 5 | Merck Global Health Innovation Fund, LLC | 3.35M | 11.80% | 3.35M | — | 3.35M | — | OO | Delaware | 2018-06-27 | ↗ |
| 6 | Merck Sharp & Dohme Corp. | 3.35M | 11.80% | 3.35M | — | 3.35M | — | CO | New Jersey | 2018-06-27 | ↗ |
| 7 | Core Ventures II, LLC | 1.80M | 6.99% | 1.80M | — | 1.80M | — | OO | USA | 2019-06-27 | ↗ |
| 8 | Kathryn Theofilos | 637.9K | 9.90% | 8.6K | 629.4K | 8.6K | — | IN | United States of America | 2023-12-18 | ↗ |
| 9 | Happy Holstein Management, LLC | 536.5K | 8.40% | — | 536.5K | — | — | OO | Florida | 2023-12-18 | ↗ |
| 10 | Charles Steve Theofilos, M.D. | 412.4K | 6.90% | 326.4K | 86.0K | 326.4K | — | IN | United States of America | 2023-12-18 | ↗ |
| 11 | Charles Steve Theofilos, MD | 412.4K | 6.90% | 326.4K | 86.0K | 326.4K | — | IN | United States of America | 2023-12-07 | ↗ |
| 12 | Reflects the distribution on or about November 19, 2019 of approximately 1.2 million shares of commo | 3.00 | 12.00% | 920.0K | — | 920.0K | — | OO | Delaware | 2019-11-25 | ↗ |
| 13 | Altium Capital Management, LP | — | 0.00% | — | — | — | — | IA, PN | Delaware, United States of America | 2022-02-14 | ↗ |
| 14 | Altium Growth Fund, LP | — | 0.00% | — | — | — | — | PN | Delaware, United States of America | 2022-02-14 | ↗ |
| 15 | Altium Growth GP, LLC | — | 0.00% | — | — | — | — | OO | Delaware, United States of America | 2022-02-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
5
-25 vs prev Q
New positions
1
Closed positions
26
Increased
1
Reduced
1
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 242.9K +9.5K (+4.1%) | 1.09M -66.1K (-5.7%) | 2.88% +0.069 pp | 0.00% +0.000 pp | USD5.83 -23.0% | 12 qtrs — |
| 2 | TEJARA CAPITAL LTD | 100.4K +100.4K (+100.0%) | 450.2K +450.2K (+100.0%) | 1.19% +1.189 pp | 0.11% +0.106 pp | USD4.49 +0.0% | 1 qtrs NEW |
| 3 | INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 88.7K +11.7K (+15.2%) | 397.9K -5.7K (-1.4%) | 1.05% +0.124 pp | 0.03% -0.005 pp | USD6.12 -26.6% | 10 qtrs — |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 70.2K +568.0 (+0.8%) | 314.9K -29.8K (-8.7%) | 0.83% -0.006 pp | 0.00% +0.000 pp | USD5.81 -22.7% | 12 qtrs — |
| 5 | DRW SECURITIES, LLC | 58.8K +58.8K (+100.0%) | 263.6K +263.6K (+100.0%) | 0.70% +0.696 pp | 0.01% +0.007 pp | USD4.49 +0.0% | 1 qtrs NEW |
| 6 | RENAISSANCE TECHNOLOGIES LLC | 54.5K -45.8K (-45.7%) | 244.4K -252.0K (-50.8%) | 0.65% -0.561 pp | 0.00% 0.000 pp | USD9.39 -52.2% | 12 qtrs — |
| 7 | JAFFETILCHIN INVESTMENT PARTNERS, LLC | 52.4K +3.6K (+7.4%) | 234.8K -6.5K (-2.7%) | 0.62% +0.034 pp | 0.01% -0.001 pp | USD5.49 -18.2% | 12 qtrs — |
| 8 | WEALTHSPIRE ADVISORS, LLC | 47.5K +— (+0.0%) | 213.0K -22.1K (-9.4%) | 0.56% -0.009 pp | 0.00% +0.001 pp | USD5.52 -18.7% | 12 qtrs — |
| 9 | HIGHTOWER ADVISORS, LLC | 35.3K +— (+0.0%) | 158.5K -16.4K (-9.4%) | 0.42% -0.007 pp | 0.00% +0.000 pp | USD7.22 -37.8% | 6 qtrs — |
| 10 | CITADEL ADVISORS LLC | 34.6K +34.6K (+100.0%) | 155.4K +155.4K (+100.0%) | 0.41% +0.410 pp | 0.00% +0.000 pp | USD4.49 +0.0% | 1 qtrs NEW |
| 11 | STATE STREET CORP | 26.5K +— (+0.0%) | 118.9K -12.3K (-9.4%) | 0.31% -0.005 pp | 0.00% +0.000 pp | USD11.27 -60.2% | 12 qtrs — |
| 12 | BLACKROCK, INC. | 26.1K +126.0 (+0.5%) | 117.0K -11.5K (-9.0%) | 0.31% -0.003 pp | 0.00% +0.000 pp | USD13.14 -65.8% | 6 qtrs — |
| 13 | TWO SIGMA INVESTMENTS, LP | 19.4K -5.2K (-21.1%) | 87.1K -34.7K (-28.5%) | 0.23% -0.066 pp | 0.00% 0.000 pp | USD5.22 -14.0% | 3 qtrs — |
| 14 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 19.2K +19.2K (+100.0%) | 86.1K +86.1K (+100.0%) | 0.23% +0.227 pp | 0.00% +0.000 pp | USD4.49 +0.0% | 1 qtrs NEW |
| 15 | FNY INVESTMENT ADVISERS, LLC | 18.4K +18.4K (+100.0%) | 82.0K +82.0K (+100.0%) | 0.22% +0.218 pp | 0.02% +0.023 pp | USD4.49 +0.0% | 1 qtrs NEW |
| 16 | NORTHERN TRUST CORP | 11.1K +— (+0.0%) | 49.9K -5.2K (-9.4%) | 0.13% -0.002 pp | 0.00% +0.000 pp | USD6.69 -32.9% | 4 qtrs — |
| 17 | TOBIAS FINANCIAL ADVISORS, INC. | 10.0K +— (+0.0%) | 44.9K -4.7K (-9.4%) | 0.12% -0.002 pp | 0.01% -0.001 pp | USD5.50 -18.4% | 12 qtrs — |
| 18 | UBS GROUP AG | 7.5K -347.0 (-4.4%) | 33.5K -5.2K (-13.4%) | 0.09% -0.006 pp | 0.00% +0.000 pp | USD6.12 -26.6% | 7 qtrs — |
| 19 | MORGAN STANLEY | 4.2K +2.8K (+194.9%) | 18.8K +11.8K (+167.2%) | 0.05% +0.033 pp | 0.00% +0.000 pp | USD7.88 -43.0% | 12 qtrs — |
| 20 | BFSG, LLC | 3.9K +— (+0.0%) | 17.3K -1.8K (-9.4%) | 0.05% -0.001 pp | 0.00% 0.000 pp | USD5.28 -15.0% | 3 qtrs — |
| 21 | ROCKEFELLER CAPITAL MANAGEMENT L.P. | 1.9K +— (+0.0%) | 8.7K -905.0 (-9.4%) | 0.02% 0.000 pp | 0.00% +0.000 pp | USD4.95 -9.3% | 2 qtrs — |
| 22 | KOZAK & ASSOCIATES, INC. | 666.00 +— (+0.0%) | 3.8K +247.0 (+7.1%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD5.50 -18.4% | 12 qtrs — |
| 23 | RIALTO WEALTH MANAGEMENT, LLC | 634.00 +— (+0.0%) | 2.8K -295.0 (-9.4%) | 0.01% 0.000 pp | 0.00% 0.000 pp | USD6.69 -32.9% | 4 qtrs — |
| 24 | WELLS FARGO & COMPANY/MN | 311.00 +— (+0.0%) | 1.4K -144.0 (-9.4%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD5.51 -18.5% | 12 qtrs — |
| 25 | TOWER RESEARCH CAPITAL LLC (TRC) | 289.00 -372.0 (-56.3%) | 1.3K -2.0K (-60.4%) | 0.00% -0.005 pp | 0.00% 0.000 pp | USD5.37 -16.4% | 12 qtrs — |
| 26 | PRESTIGE WEALTH MANAGEMENT GROUP LLC | 270.00 +— (+0.0%) | 1.2K -126.0 (-9.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.50 -18.4% | 12 qtrs — |
| 27 | BNP PARIBAS ARBITRAGE, SNC | 24.00 -111.0 (-82.2%) | 108.00 -560.0 (-83.8%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD6.92 -35.1% | 5 qtrs — |
| 28 | TUCKER ASSET MANAGEMENT LLC | 13.00 +13.0 (+100.0%) | 58.00 +58.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.46 +0.7% | 1 qtrs NEW |
| 29 | BANK OF AMERICA CORP /DE/ | 6.00 +— (+0.0%) | 27.00 -3.0 (-10.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.83 -23.0% | 9 qtrs — |
| 30 | JPMORGAN CHASE & CO | 1.00 +— (+0.0%) | 4.00 -1.0 (-20.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD16.00 -71.9% | 11 qtrs — |
| 31 | ADVISOR GROUP HOLDINGS, INC. | — -115.0 (-100.0%) | — -610.0 (-100.0%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD— | 12 qtrs SOLD |
| 32 | ROYAL BANK OF CANADA | — -231.0 (-100.0%) | — -1.0K (-100.0%) | 0.00% -0.003 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 33 | GREY FOX WEALTH ADVISORS, LLC | — -66.0 (-100.0%) | — -327.0 (-100.0%) | 0.00% -0.001 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 34 | FORTITUDE FAMILY OFFICE, LLC | — -73.0 (-100.0%) | — -361.0 (-100.0%) | 0.00% -0.001 pp | 0.00% 0.000 pp | USD— | 3 qtrs SOLD |
| 35 | BARCLAYS PLC | — -3.0 (-100.0%) | — -15.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 36 | SBI SECURITIES CO., LTD. | — -1.0 (-100.0%) | — -5.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 13 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P International Small Cap ETF GWX | 0.04% | 354.6K | 0.40% |
| 2 | iShares Micro-Cap ETF IWC | 0.01% | 115.8K | 0.60% |
| 3 | Vanguard Extended Market ETF VXF | 0.00% | 588.6K | 0.05% |
| 4 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 590.27 | 0.17% |
| 5 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 2.9K | 0.03% |
| 6 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 8.0K | 0.17% |
| 7 | Vanguard Total Stock Market ETF VTI | 0.00% | 1.37M | 0.03% |
| 8 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 3.0K | 0.22% |
| 9 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 1.6K | 0.22% |
| 10 | Vanguard Balanced ETF Portfolio VBAL.TO | 0.00% | 658.30 | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
2.00
Bullish
Ratio by volume
3.00
Bullish
Buys
2
Sells
1
Shares acquired
115.0K
Shares disposed
16.1K
Cash buys
—
Cash sales
1.00
Net activity
+98,928
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-13 | Fox Michael | Officer | A-Award | A | Common Stock | 70,000 | 0.00 | — | 70,000 | D | ↗ |
| 2026-04-10 | Goldberger Daniel S | Director / Officer | S-Sale | D | Common Stock | 16,072 | 6.02 | 96.8K | 291,471 | D | ↗ |
| 2026-04-01 | Lev Joshua S. | Officer | A-Award | A | Common Stock | 45,000 | 0.00 | — | 94,556 | D | ↗ |
| 2026-03-19 | Errico Thomas J. | Director | X-InTheMoney | A | Common Stock | 19,252 | 6.43 | 123.8K | 350,071 | D | ↗ |
| 2026-01-26 | Lev Joshua S. | Officer | A-Award | A | Common Stock | 25,000 | 0.00 | — | 49,556 | D | ↗ |
| 2026-01-26 | Goldberger Daniel S | Director / Officer | A-Award | A | Common Stock | 26,000 | 0.00 | — | 338,940 | D | ↗ |
| 2025-12-04 | Lev Joshua S. | Officer | S-Sale | D | Common Stock | 2,500 | 5.05 | 12.6K | 21,667 | D | ↗ |
| 2025-12-02 | Goldberger Daniel S | Director / Officer | P-Purchase | A | Common Stock | 1,000 | 4.84 | 4.8K | 292,565 | D | ↗ |
| 2025-11-12 | Lev Joshua S. | Officer | S-Sale | D | Common Stock | 2,166 | 6.18 | 13.4K | 23,667 | D | ↗ |
| 2025-09-10 | Bonfiglioli Elena | Director | A-Award | A | Common Stock | 30,549 | 0.00 | — | 30,549 | D | ↗ |
| 2025-09-02 | Wilber Patricia | Director | A-Award | A | Common Stock | 19,011 | 0.00 | — | 72,325 | D | ↗ |
| 2025-09-02 | PATTON THOMAS M | Director | A-Award | A | Common Stock | 19,011 | 0.00 | — | 102,782 | D | ↗ |
| 2025-09-02 | Goldstein Julie Ann | Director | A-Award | A | Common Stock | 19,011 | 0.00 | — | 101,387 | D | ↗ |
| 2025-09-02 | GANDOLFO JOHN P | Director | A-Award | A | Common Stock | 19,011 | 0.00 | — | 88,098 | D | ↗ |
| 2025-09-02 | Errico Thomas J. | Director | A-Award | A | Common Stock | 26,615 | 0.00 | — | 308,016 | D | ↗ |
| 2025-09-02 | Bonfiglioli Elena | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-08-11 | Goldberger Daniel S | Director / Officer | P-Purchase | A | Common Stock | 1,000 | 4.23 | 4.2K | 291,565 | D | ↗ |
| 2025-08-11 | Errico Thomas J. | Director | P-Purchase | A | Common Stock | 15,000 | 4.47 | 67.1K | 281,401 | D | ↗ |
| 2025-08-01 | Theofilos James Charles | Director | A-Award | A | Common Stock | 22,156 | 0.00 | — | 23,547 | D | ↗ |
| 2025-05-23 | GANDOLFO JOHN P | Director | P-Purchase | A | Common Stock | 1,800 | 5.01 | 9.0K | 69,087 | D | ↗ |
| 2025-05-12 | Errico Thomas J. | Director | P-Purchase | A | Common Stock | 10,000 | 4.77 | 47.7K | 266,401 | D | ↗ |
| 2025-03-17 | Goldberger Daniel S | Director / Officer | P-Purchase | A | Common Stock | 1,000 | 8.59 | 8.6K | 290,565 | D | ↗ |
| 2025-03-17 | Errico Thomas J. | Director | P-Purchase | A | Common Stock | 6,000 | 8.10 | 48.6K | 256,401 | D | ↗ |
| 2025-02-24 | Theofilos Charles Steve | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-01-18 | Goldberger Daniel S | Director / Officer | A-Award | A | Common Stock | 40,000 | 0.00 | — | 289,565 | D | ↗ |
| 2025-01-15 | Lev Joshua S. | Officer | A-Award | A | Common Stock | 10,000 | 0.00 | — | 26,333 | D | ↗ |
| 2024-10-04 | Lev Joshua S. | Officer | — | — | Common Stock | 0 | 0.00 | — | 16,333 | D | ↗ |
| 2024-09-03 | Wilber Patricia | Director | A-Award | A | Common Stock | 16,583 | 0.00 | — | 49,697 | — | ↗ |
| 2024-09-03 | Theofilos Charles Steve | Director | A-Award | A | Common Stock | 16,582 | 0.00 | — | 454,202 | — | ↗ |
| 2024-09-03 | PATTON THOMAS M | Director | A-Award | A | Common Stock | 16,583 | 0.00 | — | 83,771 | — | ↗ |
| 2024-09-03 | Goldstein Julie Ann | Director | A-Award | A | Stock Option (Right to Buy) | 19,845 | 6.03 | 119.7K | 19,845 | — | ↗ |
| 2024-09-03 | GANDOLFO JOHN P | Director | A-Award | A | Common Stock | 16,583 | 0.00 | — | 67,287 | — | ↗ |
| 2024-09-03 | Errico Thomas J. | Director | A-Award | A | Common Stock | 16,583 | 0.00 | — | 250,401 | — | ↗ |
| 2024-09-03 | CUNEO F PETER | Director | A-Award | A | Stock Option (Right to Buy) | 27,783 | 6.03 | 167.5K | 27,783 | — | ↗ |
| 2024-08-15 | Errico Thomas J. | Director | P-Purchase | A | Common Stock | 5,000 | 6.12 | 30.6K | 233,818 | — | ↗ |
| 2024-07-31 | Lev Joshua S. | Officer | — | — | Stock Option (Right to Buy) | 20,000 | 4.50 | 90.0K | 0 | D | ↗ |
| 2024-07-11 | CUNEO F PETER | Director | A-Award | A | Stock Option (Right to Buy) | 50,000 | 6.43 | 321.5K | 50,000 | — | ↗ |
| 2024-06-13 | GANDOLFO JOHN P | Director | P-Purchase | A | Common Stock | 1,000 | 6.43 | 6.4K | 50,704 | — | ↗ |
| 2024-06-05 | Wilber Patricia | Director | P-Purchase | A | Warrants to Purchase Common Stock | 3,465 | 6.43 | 22.3K | 3,465 | — | ↗ |
| 2024-06-05 | Theofilos Charles Steve | Director | P-Purchase | A | Common Stock Warrants (right to buy) | 385,059 | 6.43 | 2.48M | 385,059 | — | ↗ |
| 2024-06-05 | PATTON THOMAS M | Director | P-Purchase | A | Warrants to Purchase Common Stock | 3,850 | 6.43 | 24.8K | 3,850 | — | ↗ |
| 2024-06-05 | Goldstein Julie Ann | Director | P-Purchase | A | Warrants to Purchase Common Stock | 3,850 | 6.43 | 24.8K | 3,850 | — | ↗ |
| 2024-06-05 | Goldberger Daniel S | Director / Officer | P-Purchase | A | Common Stock | 38,505 | 6.43 | 247.6K | 249,565 | — | ↗ |
| 2024-06-05 | Errico Thomas J. | Director | P-Purchase | A | Warrants to Purchase Common Stock | 19,252 | 6.43 | 123.8K | 19,252 | — | ↗ |
| 2024-01-16 | Goldberger Daniel S | Director / Officer | A-Award | A | Common Stock | 75,000 | 0.00 | — | 211,060 | — | ↗ |
| 2024-01-12 | POSNER BRIAN M | Officer | P-Purchase | A | Common Stock | 16,000 | 0.00 | — | 22,437 | — | ↗ |
| 2024-01-01 | Theofilos Charles Steve | Director | A-Award | A | Common Stock | 25,210 | 0.00 | — | 437,620 | — | ↗ |
| 2023-12-08 | Theofilos Charles Steve | Director | — | I | Common Stock | 0 | 0.00 | — | 790 | — | ↗ |
| 2023-09-15 | Goldberger Daniel S | Director / Officer | P-Purchase | A | Common Stock | 1,500 | 5.56 | 8.3K | 136,060 | — | ↗ |
| 2023-08-04 | PATTON THOMAS M | Director | A-Award | A | Common Stock | 21,739 | 0.00 | — | 59,487 | — | ↗ |
| 2023-08-04 | Goldstein Julie Ann | Director | A-Award | A | Stock Option (Right to Buy) | 25,989 | 4.60 | 119.5K | 25,989 | — | ↗ |
| 2023-08-04 | Goldberger Daniel S | Director / Officer | P-Purchase | A | Common Stock | 50,000 | 0.00 | — | 134,560 | — | ↗ |
| 2023-08-04 | GANDOLFO JOHN P | Director | A-Award | A | Common Stock | 21,739 | 0.00 | — | 49,704 | — | ↗ |
| 2023-08-04 | Errico Thomas J. | Director | A-Award | A | Common Stock | 21,739 | 0.00 | — | 189,606 | — | ↗ |
| 2023-08-04 | CUNEO F PETER | Director | A-Award | A | Stock Option (Right to Buy) | 36,383 | 4.60 | 167.4K | 36,383 | — | ↗ |
| 2023-08-02 | Wilber Patricia | Director | A-Award | A | Common Stock | 21,739 | 0.00 | — | 26,183 | — | ↗ |
| 2023-08-02 | PATTON THOMAS M | Director | P-Purchase | A | Warrants to Purchase Common Stock | 5,524 | 4.35 | 24.0K | 5,524 | — | ↗ |
| 2023-08-02 | Moody Trevor J | Director | P-Purchase | A | Warrants to Purchase Common Stock | 11,331 | 4.37 | 49.5K | 11,331 | — | ↗ |
| 2023-08-02 | Goldstein Julie Ann | Director | A-Award | A | Common Stock | 33,994 | 4.35 | 147.9K | 69,679 | — | ↗ |
| 2023-08-02 | Goldberger Daniel S | Director / Officer | P-Purchase | A | Warrants to Purchase Common Stock | 25,495 | 4.35 | 110.9K | 25,495 | — | ↗ |
| 2023-08-02 | Errico Thomas J. | Director | P-Purchase | A | Warrants to Purchase Common Stock | 22,803 | 4.35 | 99.2K | 22,803 | — | ↗ |
| 2023-08-02 | CUNEO F PETER | Director | A-Award | A | Common Stock | 5,665 | 4.35 | 24.6K | 5,665 | — | ↗ |
| 2023-07-31 | POSNER BRIAN M | Officer | A-Award | A | Stock Option (Right to Buy) | 20,000 | 4.50 | 90.0K | 20,000 | — | ↗ |
| 2023-03-17 | Goldberger Daniel S | Director / Officer | P-Purchase | A | Common Stock | 500 | 3.43 | 1.7K | 33,569 | — | ↗ |
| 2023-03-16 | Goldberger Daniel S | Director / Officer | P-Purchase | A | Common Stock | 500 | 3.46 | 1.7K | 33,069 | — | ↗ |
| 2023-03-15 | Goldberger Daniel S | Director / Officer | P-Purchase | A | Common Stock | 500 | 3.55 | 1.8K | 467,542 | — | ↗ |
| 2023-03-14 | Goldberger Daniel S | Director / Officer | P-Purchase | A | Common Stock | 500 | 3.73 | 1.9K | 467,042 | — | ↗ |
| 2023-03-13 | Goldberger Daniel S | Director / Officer | P-Purchase | A | Common Stock | 500 | 3.86 | 1.9K | 466,542 | — | ↗ |
| 2023-03-13 | Errico Thomas J. | Director | A-Award | A | Common Stock | 6,750 | 3.61 | 24.4K | 122,260 | — | ↗ |
| 2023-01-14 | Lev Joshua S. | Officer | — | — | Stock Option (Right to Buy) | 6,666 | 11.55 | 77.0K | 0 | D | ↗ |
| 2022-12-14 | Goldberger Daniel S | Officer | P-Purchase | A | Common Stock | 5,000 | 0.35 | 1.7K | 466,042 | — | ↗ |
| 2022-12-13 | Goldberger Daniel S | Officer | P-Purchase | A | Common Stock | 5,000 | 0.33 | 1.6K | 461,042 | — | ↗ |
| 2022-12-13 | Errico Joseph P | Director | P-Purchase | A | Common Stock | 100,000 | 0.33 | 33.3K | 2,724,841 | — | ↗ |
| 2022-12-12 | Goldberger Daniel S | Officer | P-Purchase | A | Common Stock | 5,000 | 0.32 | 1.6K | 456,042 | — | ↗ |
| 2022-12-09 | Goldberger Daniel S | Officer | P-Purchase | A | Common Stock | 5,000 | 0.30 | 1.5K | 451,042 | — | ↗ |
| 2022-12-08 | Goldberger Daniel S | Officer | P-Purchase | A | Common Stock | 10,000 | 0.28 | 2.8K | 446,042 | — | ↗ |
| 2022-12-02 | PATTON THOMAS M | Director | A-Award | A | Common Stock | 205,987 | 0.00 | — | 400,497 | — | ↗ |
| 2022-12-02 | Moody Trevor J | Director | A-Award | A | Common Stock | 205,987 | 0.00 | — | 673,952 | — | ↗ |
| 2022-12-02 | GANDOLFO JOHN P | Director | A-Award | A | Common Stock | 205,987 | 0.00 | — | 419,497 | — | ↗ |
| 2022-12-02 | Errico Thomas J. | Director | A-Award | A | Common Stock | 205,987 | 0.00 | — | 1,732,687 | — | ↗ |
| 2022-12-02 | Errico Joseph P | Director | A-Award | A | Common Stock | 205,987 | 0.00 | — | 2,624,841 | — | ↗ |
| 2022-12-02 | CUNEO F PETER | Director | A-Award | A | Stock Option (Right to Buy) | 322,534 | 0.00 | — | 322,534 | — | ↗ |
| 2022-11-29 | Errico Joseph P | Director | P-Purchase | A | Common Stock | 25,000 | 0.33 | 8.3K | 2,418,854 | — | ↗ |
| 2022-11-25 | Errico Joseph P | Director | P-Purchase | A | Common Stock | 50,000 | 0.31 | 15.7K | 2,393,854 | — | ↗ |
| 2022-11-23 | Errico Joseph P | Director | P-Purchase | A | Common Stock | 100,000 | 0.31 | 31.1K | 2,343,854 | — | ↗ |
| 2022-11-22 | Errico Joseph P | Director | P-Purchase | A | Common Stock | 75,000 | 0.33 | 25.0K | 2,243,854 | — | ↗ |
| 2022-11-17 | Errico Joseph P | Director | P-Purchase | A | Common Stock | 100,000 | 0.31 | 31.2K | 2,168,854 | — | ↗ |
| 2022-11-16 | Errico Joseph P | Director | P-Purchase | A | Common Stock | 100,000 | 0.29 | 29.3K | 2,068,854 | — | ↗ |
| 2022-11-14 | Errico Joseph P | Director | P-Purchase | A | Common Stock | 100,000 | 0.24 | 24.0K | 1,968,854 | — | ↗ |
| 2022-11-10 | Errico Joseph P | Director | P-Purchase | A | Common Stock | 100,000 | 0.24 | 24.5K | 1,868,854 | — | ↗ |
| 2022-11-08 | Errico Thomas J. | Director | P-Purchase | A | Common Stock | 100,000 | 0.22 | 22.0K | 1,526,700 | — | ↗ |
| 2022-06-13 | Errico Joseph P | Director | P-Purchase | A | Common Stock | 100,000 | 0.56 | 55.8K | 1,765,651 | — | ↗ |
| 2022-05-27 | Moody Trevor J | Director | P-Purchase | A | Common Stock | 39,478 | 0.44 | 17.4K | 423,455 | — | ↗ |
| 2022-05-23 | Goldstein Julie Ann | Director | A-Award | A | Common Stock | 100,000 | 0.40 | 39.6K | 460,212 | — | ↗ |
| 2022-05-19 | Errico Thomas J. | Director | P-Purchase | A | Common Stock | 15,197 | 0.40 | 6.0K | 1,426,700 | — | ↗ |
| 2022-05-18 | Errico Thomas J. | Director | P-Purchase | A | Common Stock | 42,032 | 0.40 | 16.7K | 1,411,503 | — | ↗ |
| 2022-05-17 | GANDOLFO JOHN P | Director | P-Purchase | A | Common Stock | 15,000 | 0.36 | 5.4K | 19,000 | — | ↗ |
| 2022-05-17 | Errico Thomas J. | Director | P-Purchase | A | Common Stock | 42,771 | 0.39 | 16.7K | 1,369,471 | — | ↗ |
| 2022-05-16 | Goldberger Daniel S | Officer | P-Purchase | A | Common Stock | 28,208 | 0.34 | 9.6K | 328,516 | — | ↗ |
| 2022-03-15 | Wilber Patricia | Director | A-Award | A | Common Stock | 150,000 | 0.00 | — | 150,000 | — | ↗ |
| 2022-03-15 | Goldstein Julie Ann | Director | A-Award | A | Common Stock | 150,000 | 0.00 | — | 510,212 | — | ↗ |
| 2022-01-17 | Goldberger Daniel S | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 250,000 | 0.77 | 192.5K | 250,000 | — | ↗ |
| 2022-01-14 | POSNER BRIAN M | Officer | A-Award | A | Stock Option (Right to Buy) | 100,000 | 0.77 | 77.0K | 100,000 | — | ↗ |
| 2021-12-10 | POSNER BRIAN M | Officer | P-Purchase | A | Common Stock | 10,000 | 0.75 | 7.5K | 96,555 | — | ↗ |
| 2021-12-07 | Goldberger Daniel S | Director / Officer | P-Purchase | A | Common Stock | 15,000 | 0.71 | 10.6K | 300,308 | — | ↗ |
| 2021-11-23 | Goldberger Daniel S | Director / Officer | P-Purchase | A | Common Stock | 15,000 | 0.75 | 11.2K | 285,308 | — | ↗ |
| 2021-11-09 | POSNER BRIAN M | Officer | P-Purchase | A | Common Stock | 10,000 | 0.96 | 9.6K | 86,555 | — | ↗ |
| 2021-10-01 | Goldberger Daniel S | Director / Officer | M-Exempt | A | Common Stock | 53,764 | 0.00 | — | 270,308 | — | ↗ |
| 2021-08-17 | POSNER BRIAN M | Officer | S-Sale | D | Common Stock | 6,478 | 0.92 | 6.0K | 76,555 | — | ↗ |
| 2021-07-02 | Moody Trevor J | Director | P-Purchase | A | Common Stock | 100,000 | 1.00 | 100.0K | 373,455 | — | ↗ |
| 2021-07-02 | Goldberger Daniel S | Director / Officer | P-Purchase | A | Common Stock | 50,000 | 1.00 | 50.0K | 216,544 | — | ↗ |
| 2021-07-02 | Errico Thomas J. | Director | P-Purchase | A | Common Stock | 50,000 | 1.00 | 50.0K | 1,326,700 | — | ↗ |
| 2021-06-11 | PATTON THOMAS M | Director | A-Award | A | Restricted Stock Units | 44,510 | 0.00 | — | 44,510 | — | ↗ |
| 2021-06-11 | Ondra Stephen | Director | A-Award | A | Restricted Stock Units | 44,510 | 0.00 | — | 44,510 | — | ↗ |
| 2021-06-11 | Moody Trevor J | Director | A-Award | A | Restricted Stock Units | 44,510 | 0.00 | — | 44,510 | — | ↗ |
| 2021-06-11 | GANDOLFO JOHN P | Director | A-Award | A | Deferred Stock Units | 44,510 | 0.00 | — | 44,510 | — | ↗ |
| 2021-06-11 | Errico Thomas J. | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 67,568 | 1.69 | 114.2K | 67,568 | — | ↗ |
| 2021-06-11 | Errico Joseph P | Director | A-Award | A | Deferred Stock Units | 44,510 | 0.00 | — | 44,510 | — | ↗ |
| 2021-06-11 | CUNEO F PETER | Director | A-Award | A | Stock Option (Right to Buy) | 67,568 | 1.69 | 114.2K | 67,568 | — | ↗ |
| 2021-06-11 | ATIEH MICHAEL G | Director | A-Award | A | Deferred Stock Units | 66,766 | 0.00 | — | 66,766 | — | ↗ |
| 2021-05-17 | Errico Thomas J. | Director | P-Purchase | A | Common Stock | 31,250 | 1.59 | 49.7K | 1,275,700 | — | ↗ |
| 2021-03-16 | GANDOLFO JOHN P | Director | P-Purchase | A | Common Stock | 4,000 | 2.15 | 8.6K | 4,000 | — | ↗ |
| 2021-01-25 | Goldberger Daniel S | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 270,000 | 2.66 | 718.2K | 270,000 | — | ↗ |
| 2021-01-18 | POSNER BRIAN M | Officer | A-Award | A | Stock Option (Right to Buy) | 250,000 | 1.77 | 442.5K | 250,000 | — | ↗ |
| 2020-06-12 | POSNER BRIAN M | Officer | A-Award | A | Stock Option (Right to Buy) | 105,000 | 1.40 | 147.0K | 105,000 | — | ↗ |
| 2020-06-12 | Ondra Stephen | Director | A-Award | A | Restricted Stock Units | 75,000 | 0.00 | — | 75,000 | — | ↗ |
| 2020-06-12 | Moody Trevor J | Director | A-Award | A | Restricted Stock Units | 75,000 | 0.00 | — | 75,000 | — | ↗ |
| 2020-06-12 | Errico Thomas J. | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 75,000 | 0.99 | 74.3K | 75,000 | — | ↗ |
| 2020-06-12 | Errico Joseph P | Director / 10% Owner | A-Award | A | Deferred Stock Units | 75,000 | 0.00 | — | 75,000 | — | ↗ |
| 2020-06-12 | ATIEH MICHAEL G | Director | A-Award | A | Deferred Stock Units | 112,500 | 0.00 | — | 112,500 | — | ↗ |
| 2020-04-14 | TULLIS JAMES L L | Director | P-Purchase | A | Common Stock | 1,764,705 | 0.85 | 1.50M | 1,764,705 | — | ↗ |
| 2020-04-14 | Moody Trevor J | Director | P-Purchase | A | Common Stock | 116,647 | 0.85 | 99.1K | 177,944 | — | ↗ |
| 2020-04-14 | Errico Thomas J. | Director | P-Purchase | A | Common Stock | 176,470 | 0.85 | 150.0K | 1,245,450 | — | ↗ |
| 2020-04-02 | PATTON THOMAS M | Director | A-Award | A | Common Stock | 150,000 | 0.00 | — | 150,000 | — | ↗ |
| 2020-04-02 | GANDOLFO JOHN P | Director | A-Award | A | Deferred Stock Units | 150,000 | 0.00 | — | 150,000 | — | ↗ |
| 2020-04-02 | CUNEO F PETER | Director | A-Award | A | Stock Option (Right to Buy) | 150,000 | 0.75 | 112.0K | 150,000 | — | ↗ |
| 2020-03-11 | POSNER BRIAN M | Officer | — | D | Stock Option | 105,000 | 8.06 | 846.3K | 0 | — | ↗ |
| 2019-12-12 | TULLIS JAMES L L | Director | J-Other | A | Common Stock | 98,918 | 0.00 | — | 0 | — | ↗ |
| 2019-11-22 | TULLIS JAMES L L | Director | P-Purchase | A | Common Stock | 4,984 | 1.43 | 7.1K | 163,824 | — | ↗ |
| 2019-11-19 | Core Ventures II, LLC | 10% Owner | J-Other | D | Common Stock | 1,156,494 | 0.00 | — | 646,342 | — | ↗ |
| 2019-10-01 | Goldberger Daniel S | Director / Officer | A-Award | A | Stock Option | 764,331 | 1.86 | 1.42M | 764,331 | — | ↗ |
| 2019-08-19 | Errico Thomas J. | Director | A-Award | A | Common Stock | 707 | 26.43 | 18.7K | 168,574 | — | ↗ |
| 2019-08-16 | TULLIS JAMES L L | Director | P-Purchase | A | Common Stock | 47,613 | 1.64 | 78.1K | 158,840 | — | ↗ |
| 2019-08-16 | Errico Thomas J. | Director | P-Purchase | A | Common Stock | 18,974 | 1.62 | 30.7K | 883,237 | — | ↗ |
| 2019-06-27 | POSNER BRIAN M | Officer | A-Award | A | Restricted Stock Units | 73,033 | 0.00 | — | 73,033 | — | ↗ |
| 2019-06-24 | Core Ventures II, LLC | 10% Owner | J-Other | D | Common Stock | 4,697,813 | 0.00 | — | 1,802,836 | — | ↗ |
| 2019-06-07 | TULLIS JAMES L L | Director | A-Award | A | Deferred Stock Units | 44,642 | 0.00 | — | 44,642 | — | ↗ |
| 2019-06-07 | Ondra Stephen | Director | A-Award | A | Stock Option (Right to Buy) | 63,291 | 2.24 | 141.8K | 63,291 | — | ↗ |
| 2019-06-07 | Moody Trevor J | Director | A-Award | A | Restricted Stock Units | 44,642 | 0.00 | — | 44,642 | — | ↗ |
| 2019-06-07 | Errico Thomas J. | Director / 10% Owner | P-Purchase | A | Common Stock | 7,000 | 1.77 | 12.4K | 484,651 | — | ↗ |
| 2019-06-07 | Colucci Nicholas | Director | A-Award | A | Restricted Stock Units | 44,642 | 0.00 | — | 44,642 | — | ↗ |
| 2019-06-07 | COX CARRIE SMITH | Director | A-Award | A | Deferred Stock Units | 66,964 | 0.00 | — | 66,964 | — | ↗ |
| 2019-06-07 | Amato Francis R. | Director / Officer | A-Award | A | Restricted Stock Units | 22,321 | 0.00 | — | 22,321 | — | ↗ |
| 2019-06-07 | ATIEH MICHAEL G | Director | A-Award | A | Stock Option (Right to Buy) | 63,291 | 2.24 | 141.8K | 63,291 | — | ↗ |
| 2019-06-06 | POSNER BRIAN M | Officer | P-Purchase | A | Common Stock | 10,000 | 1.72 | 17.2K | 10,000 | — | ↗ |
| 2019-06-06 | Errico Thomas J. | Director / 10% Owner | P-Purchase | A | Common Stock | 15,000 | 1.82 | 27.3K | 471,651 | — | ↗ |
| 2019-06-06 | COX CARRIE SMITH | Director | P-Purchase | A | Common Stock | 10,000 | 1.82 | 18.2K | 21,000 | — | ↗ |
| 2019-04-12 | Errico Joseph P | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 25,869 | 5.53 | 143.1K | 532,349 | — | ↗ |
| 2019-04-11 | Errico Joseph P | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 13,723 | 5.49 | 75.3K | 558,218 | — | ↗ |
| 2019-04-01 | Errico Joseph P | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 10,408 | 6.97 | 72.5K | 571,941 | — | ↗ |
| 2019-04-01 | Amato Francis R. | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 307,125 | 6.72 | 2.06M | 307,125 | — | ↗ |
| 2019-03-28 | Staats Peter S. | Officer | A-Award | A | Common Stock | 8,976 | 0.00 | — | 163,612 | — | ↗ |
| 2019-03-22 | Vraniak Glenn S. | Officer | A-Award | A | Restricted Stock | 2,976 | 8.40 | 25.0K | 120,811 | — | ↗ |
| 2019-01-17 | Errico Joseph P | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 7,841 | 4.84 | 38.0K | 582,349 | — | ↗ |
| 2019-01-16 | Errico Joseph P | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 19,810 | 4.89 | 96.9K | 590,190 | — | ↗ |
| 2019-01-15 | Errico Joseph P | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 22,349 | 4.90 | 109.5K | 610,000 | — | ↗ |
| 2019-01-11 | Core Ventures II, LLC | 10% Owner | J-Other | D | Common Stock | 1,232,056 | 0.00 | — | 6,500,649 | — | ↗ |
| 2019-01-01 | Vraniak Glenn S. | Officer | — | D | Stock Options | 136,935 | 15.00 | 2.05M | 0 | — | ↗ |
| 2019-01-01 | TULLIS JAMES L L | Director | — | D | Stock Options | 163 | 15.00 | 2.4K | 0 | — | ↗ |
| 2019-01-01 | Staats Peter S. | Officer | — | D | Stock Option | 130,935 | 15.00 | 1.96M | 0 | — | ↗ |
| 2019-01-01 | Moody Trevor J | Director | — | D | Stock Options | 2,834 | 15.00 | 42.5K | 0 | — | ↗ |
| 2019-01-01 | Errico Thomas J. | Director / 10% Owner | — | D | Stock Option | 4,402 | 15.00 | 66.0K | 0 | — | ↗ |
| 2019-01-01 | Errico Joseph P | Director / Officer / 10% Owner | — | D | Stock Option | 530,851 | 15.00 | 7.96M | 0 | — | ↗ |
| 2019-01-01 | Colucci Nicholas | Director | — | D | Stock Option | 7,079 | 15.00 | 106.2K | 0 | — | ↗ |
| 2019-01-01 | Amato Francis R. | Director / Officer | — | D | Stock Options | 583,812 | 15.00 | 8.76M | 0 | — | ↗ |
| 2018-12-13 | Staats Peter S. | Officer | P-Purchase | A | Common Stock | 10,000 | 4.83 | 48.3K | 154,636 | — | ↗ |
| 2018-12-06 | Amato Francis R. | Director / Officer | P-Purchase | A | Common Stock | 7,500 | 6.53 | 49.0K | 358,831 | — | ↗ |
| 2018-12-03 | COX CARRIE SMITH | Director | P-Purchase | A | Common Stock | 6,400 | 6.79 | 43.5K | 10,100 | — | ↗ |
| 2018-08-17 | COX CARRIE SMITH | Director | P-Purchase | A | Common Stock | 3,700 | 13.76 | 50.9K | 17,033 | — | ↗ |
| 2018-06-21 | Vraniak Glenn S. | Officer | — | D | Common Stock | 0 | 0.00 | — | 117,835 | — | ↗ |
| 2018-06-21 | TULLIS JAMES L L | Director | — | D | Common Stock | 0 | 0.00 | — | 111,227 | — | ↗ |
| 2018-06-21 | Staats Peter S. | Officer | — | I | Common Stock | 0 | 0.00 | — | 12,843 | — | ↗ |
| 2018-06-21 | Ondra Stephen | Director | — | D | Stock Option | 22,846 | 15.00 | 342.7K | 0 | — | ↗ |
| 2018-06-21 | Moody Trevor J | Director | — | D | Common Stock | 0 | 0.00 | — | 37,166 | — | ↗ |
| 2018-06-21 | Merck Global Health Innovation Fund, LLC | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 3,179,366 | — | ↗ |
| 2018-06-21 | Errico Thomas J. | Director / 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 13,076 | — | ↗ |
| 2018-06-21 | Errico Joseph P | Director / Officer / 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 632,349 | — | ↗ |
| 2018-06-21 | Core Ventures II, LLC | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 7,732,705 | — | ↗ |
| 2018-06-21 | Colucci Nicholas | Director | — | I | Common Stock | 0 | 0.00 | — | 22,398 | — | ↗ |
| 2018-06-21 | COX CARRIE SMITH | Director | — | D | Common Stock | 0 | 0.00 | — | 13,333 | — | ↗ |
| 2018-06-21 | Amato Francis R. | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 351,331 | — | ↗ |
| 2018-06-21 | ATIEH MICHAEL G | Director | — | I | Common Stock | 0 | 0.00 | — | 55,556 | — | ↗ |
| 2016-06-29 | Staats Peter S. | Officer | — | I | Warrant | 11,884 | 12.60 | 149.7K | 0 | — | ↗ |
| 2016-06-29 | Errico Thomas J. | Director / 10% Owner | — | I | Warrant | 10,417 | 12.60 | 131.3K | 0 | — | ↗ |
| 2016-06-29 | Errico Joseph P | Director / Officer / 10% Owner | — | I | Warrant | 3,671 | 12.60 | 46.3K | 0 | — | ↗ |
| 2016-06-29 | Core Ventures II, LLC | 10% Owner | — | D | Warrant | 273,690 | 12.60 | 3.45M | 0 | — | ↗ |
| 2016-06-29 | Colucci Nicholas | Director | — | I | Warrant | 603 | 12.60 | 7.6K | 0 | — | ↗ |
| 2016-06-29 | ATIEH MICHAEL G | Director | — | I | Warrant | 3,968 | 12.60 | 50.0K | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-180.2K
Shares Outstanding
8.08M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Daniel S. Goldberger Chief Executive Officer | 631.1K | 473.3K | 486.0K | — | — | 28.3K | 1.62M | 30.03% | ↗ |
| 2 | 2024 | Joshua S. Lev Former Chief Strategy Officer Current Chief Financial Officer | 408.2K | 170.0K | 98.7K | — | — | 26.9K | 703.8K | 14.03% | ↗ |
| 3 | 2024 | Brian Posner Chief Financial Officer | 383.0K | — | 98.7K | — | — | 15.8K | 497.6K | 19.84% | ↗ |
| 4 | 2023 | Daniel S. Goldberger Chief Executive Officer | 601.0K | 420.7K | 230.0K | — | — | 29.6K | 1.28M | 17.95% | ↗ |
| 5 | 2023 | Brian M. Posner Chief Financial Officer | 415.0K | 166.0K | — | 79.4K | — | 18.9K | 679.3K | 11.69% | ↗ |
| 6 | 2023 | Brian Posner Chief Financial Officer | 415.0K | 166.0K | — | 79.4K | — | 18.9K | 679.3K | 11.69% | ↗ |
| 7 | 2023 | Joshua S. Lev Former Chief Strategy Officer Current Chief Financial Officer | 384.7K | 130.0K | — | 79.4K | — | 25.0K | 619.2K | 12.83% | ↗ |
| 8 | 2022 | Daniel S. Goldberger Chief Executive Officer | 556.5K | 278.3K | — | 136.9K | — | 25.9K | 997.6K | 13.72% | ↗ |
| 9 | 2022 | Brian Posner Chief Financial Officer | 387.0K | 154.8K | — | 54.8K | — | 18.3K | 614.8K | 8.91% | ↗ |
| 10 | 2022 | Brian M. Posner Chief Financial Officer | 387.0K | 154.8K | — | 54.8K | — | 18.3K | 614.8K | 8.91% | ↗ |
| 11 | 2021 | Daniel S. Goldberger Chief Executive Officer | 525.0K | 262.0K | — | 493.7K | — | 23.7K | 1.30M | 37.85% | ↗ |
| 12 | 2021 | Brian Posner Chief Financial Officer | 365.0K | 146.0K | — | 301.2K | — | 23.3K | 835.5K | 36.05% | ↗ |
| 13 | 2020 | Daniel S. Goldberger Chief Executive Officer | 500.0K | 300.0K | — | — | — | 119.6K | 919.6K | 0.00% | ↗ |
| 14 | 2020 | Brian Posner Chief Financial Officer | 341.7K | 238.0K | — | 96.7K | — | 22.0K | 698.3K | 13.84% | ↗ |
| 15 | 2019 | Francis R. Amato Former Chief Executive Officer | 1.13M | — | 735.8K | 1.57M | — | 48.3K | 3.49M | 66.09% | ↗ |
| 16 | 2019 | Daniel S. Goldberger Chief Executive Officer | 125.0K | 62.5K | 400.0K | 1.20M | — | — | 1.79M | 89.52% | ↗ |
| 17 | 2019 | Joseph P. Errico Former Chief Science and Strategy Officer | 753.9K | — | 172.7K | 518.1K | — | 22.4K | 1.47M | 47.09% | ↗ |
| 18 | 2019 | Peter S. Staats, MD Chief Medical Officer | 72.9K | — | 464.9K | 501.9K | — | 165.5K | 1.21M | 80.22% | ↗ |
| 19 | 2019 | Brian Posner Chief Financial Officer | 263.5K | 100.0K | 130.0K | 618.5K | — | 17.0K | 1.13M | 66.29% | ↗ |
| 20 | 2018 | Francis R. Amato Chief Executive Officer, Director | 446.1K | 250.0K | — | 487.5K | 150.0K | 20.4K | 1.35M | 36.00% | ↗ |
| 21 | 2018 | Francis R. Amato Former Chief Executive Officer | 446.1K | 250.0K | — | 487.5K | 150.0K | 20.4K | 1.35M | 36.00% | ↗ |
| 22 | 2018 | Joseph P. Errico Former Chief Science and Strategy Officer | 389.8K | 125.0K | — | 442.0K | 150.0K | 20.4K | 1.13M | 39.21% | ↗ |
| 23 | 2018 | Joseph P. Errico Chief Science Strategy Officer, Director | 389.8K | 125.0K | — | 442.0K | 150.0K | 20.4K | 1.13M | 39.21% | ↗ |
| 24 | 2018 | Peter S. Staats, M.D. Former Chief Medical Officer | 338.3K | 105.0K | — | 260.0K | — | 20.4K | 723.7K | 35.93% | ↗ |
| 25 | 2018 | Peter S. Staats, MD Chief Medical Officer | 338.3K | 105.0K | — | 260.0K | — | 20.4K | 723.7K | 35.93% | ↗ |
| 26 | 2018 | Brian Posner Chief Financial Officer | — | — | — | — | — | — | — | — | ↗ |
| 27 | 2018 | Daniel S. Goldberger Chief Executive Officer | — | — | — | — | — | — | — | — | ↗ |
| 28 | 2017 | Francis R. Amato Chief Executive Officer, Director | 400.0K | 70.0K | — | 156.5K | 125.0K | 16.4K | 767.8K | 20.38% | ↗ |
| 29 | 2017 | Joseph P. Errico Chief Science Strategy Officer, Director | 350.0K | 70.0K | — | 104.8K | — | 16.4K | 541.2K | 19.37% | ↗ |
| 30 | 2017 | Peter S. Staats, M.D. Former Chief Medical Officer | 151.7K | 10.0K | — | 30.0K | — | 6.8K | 198.5K | 15.11% | ↗ |
CEO compensation breakdown
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Daniel S. Goldberger | Chief Executive Officer & Director | 848.5K | male |
| Joshua S. Lev | CFO & Interim President | 528.9K | male |
| Peter S. Staats | Chief Medical Officer | 238.4K | — |
| Thomas J. Errico | Founder & Independent Chairman | 75.0K | — |
| Jennifer A. Hayes | Vice President of HR & Employee Success | — | female |
| Donald Melnikoff | Senior Vice President of Engineering, Regulatory & Compliance | — | male |
| Manuel A. Marques | Senior Vice President of Operations | — | male |
| Michael Fox | Chief Operating Officer | — | male |
| Mitch Deshon | Vice President of Global Sales & Business Development | — | male |
| Andy Brown | Vice President & Corporate Controller | — | male |
| Amanda Yanuklis | Chief of Staff | — | female |
ESG Rating
ESG Score History MEDICAL - DEVICES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ECOR
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
